Loading...

BioGaia AB (publ)

BIOGY•PNK
Healthcare
Drug Manufacturers - Specialty & Generic
$9.50
$0.00(0.00%)

BioGaia AB (publ) (BIOGY) Stock Overview

Explore BioGaia AB (publ)’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

B+

Score: 73.2/100

Key Financials

Market Cap961M
P/E Ratio32.18
EPS (TTM)$0.30
ROE0.18%
Fundamental Analysis

AI Price Forecasts

1 Week$8.14
1 Month$8.55
3 Months$10.08
1 Year Target$11.69

BIOGY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BioGaia AB (publ) (BIOGY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 29.16, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $11.69.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 32.18 and a market capitalization of 961M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
N/A
3-Month Change
4.00%
6-Month Change
-9.57%
Year-to-Date (YTD) Change
4.00%
1-Year Change
-13.98%
3-Year Change
-13.26%
5-Year Change
29.68%
All-Time (Max) Change
60.00%

Contact Information

https://www.biogaia.com
46 8 55 52 93 00
Kungsbroplan 3, Stockholm, 112 27

Company Facts

224 Employees
IPO DateJan 8, 2021
CountrySE
Actively Trading

Frequently Asked Questions

;